UCB Pharma (United States)

539 papers and 12.8k indexed citations i.

About

In recent decades, authors affiliated with UCB Pharma (United States) have published 539 papers, which have received a total of 12.8k indexed citations. Scholars at this organization have produced 198 papers in Psychiatry and Mental health, 185 papers in Pediatrics, Perinatology and Child Health and 152 papers in Immunology on the topics of Epilepsy research and treatment (183 papers), Pharmacological Effects and Toxicity Studies (164 papers) and Psoriasis: Treatment and Pathogenesis (104 papers). Their work is cited by papers focused on Psychiatry and Mental health (5.1k citations), Pediatrics, Perinatology and Child Health (4.5k citations) and Rheumatology (3.4k citations). Authors at UCB Pharma (United States) collaborate with scholars in United States, Belgium and Germany and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of UCB Pharma (United States)'s most productive authors include John Whitesides, Lars Bauer, Désirée van der Heijde, Mahnaz Asgharnejad and Jimmy Schiemann.

In The Last Decade

Fields of papers published by authors at UCB Pharma (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with UCB Pharma (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at UCB Pharma (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (United States) more than expected).

Rankless by CCL
2025